跳至主要内容
临床试验/NCT06159582
NCT06159582已完成不适用

eSTEP: An Integrated mHealth Intervention to Engage High-risk Individuals Along the Full PrEP Care Continuum

San Diego State University2 个研究点 分布在 1 个国家目标入组 113 人开始时间: 2024年4月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
113
试验地点
2
主要终点
Protective Levels of PrEP

研究概览

简要总结

The long-term goal of this research is to develop a theoretically grounded, effective, accessible and sustainable mHealth PrEP care continuum intervention for men who have sex with men (MSM) and transgender women (TW).

To reach this goal, the investigators will compare study outcomes among persons randomized to receive a mobile app (eSTEP) intervention tailored to the needs of MSM and TW plus usual PrEP care to a group of persons who only receive usual PrEP care.

详细描述

Study Design:

The investigators propose to evaluate the feasibility, acceptability, and preliminary impact of eSTEP in a pilot RCT with MSM and TW who are either PrEP naïve or have not been taking PrEP for at least 3 months, randomized (2:1) to receive either the eSTEP intervention or usual PrEP prevention services, and followed for 6 months with assessments at baseline, 12- and 24-weeks. eSTEP is a mobile application (i.e., app) with interactive PrEP components to increase PrEP uptake, and components to optimize PrEP retention and adherence.

eSTEP is grounded in the Information, Motivation, Behavioral Skills model [IMB] and includes the following components:

  • PrEP information
  • Identifying and addressing barriers to starting PrEP
  • Information about stigma and managing stigma
  • Matching the best PrEP option to one's personal life circumstances
  • Appointment Scheduling
  • PrEP Adherence Reminders & Self-monitoring for those who start PrEP
  • PrEP Appointment Reminders
  • A Frequently Asked Question (FAQ) Control arm participants will not be offered the eSTEP mobile app, but both the eSTEP arm and control arm will be asked to attend a brief telephone visit with a PrEP navigator, which is usual care for the clinic.

Study Sample:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • 18 years of age or older
  • Assigned male sex at birth
  • Current male & MSM identity OR transfeminine (woman, transgender woman, or non-binary) identification
  • Self-reported HIV-negative status
  • English-speaking (since the pilot intervention will be developed in English)
  • Owner of an Android or iPhone mobile device and access to this phone during the 6-month study.
  • Willingness and ability to attend HIV prevention visits at the HIV treatment and prevention clinic.
  • Consent to allow study team access to study-relevant PHI
  • Eligible for PrEP following CDC guidelines (in the past 6 months had a sexual partner with HIV with unknown or detectable viral load, inconsistently used condoms, and/or was diagnosed with a sexually transmitted infection)
  • Has never used PrEP or has not used PrEP in the past 3 months

排除标准

  • Was a Community Advisory Board Member or participant in the eSTEP focus groups
  • Assigned female or intersex at birth
  • Living with HIV
  • Already taking PrEP
  • Under 18 years old
  • Does not own a mobile phone
  • Does not speak or read English (since the pilot intervention will be developed in English)

研究组 & 干预措施

Control Arm

Placebo Comparator

Usual PrEP clinical care

干预措施: Usual Care (Behavioral)

结局指标

主要结局

Protective Levels of PrEP

时间窗: Throughout the 24 weeks of study participation, starting after PrEP initiation

Percentage of participants who achieve protective levels of PrEP depending on the type of PrEP participants are taking: 1) if taking daily oral or 2-1-1 PrEP, protective level of PrEP is defined by drug level thresholds in the blood; 2) if taking injectable PrEP, protective level of PrEP is defined by timely (+/- 1 week for the second injection; +/- 2 weeks for any subsequent injection) administration.

PrEP Initiation

时间窗: Within 24 weeks of enrollment

Percentage of study participants who initiate PrEP

次要结局

  • PrEP Persistence(Throughout the 24 weeks of study participation, starting after PrEP initiation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Keith Horvath

Professor

San Diego State University

研究点 (2)

Loading locations...

相似试验